163 related articles for article (PubMed ID: 36077072)
1. Compound C Inhibits Renca Renal Epithelial Carcinoma Growth in Syngeneic Mouse Models by Blocking Cell Cycle Progression, Adhesion and Invasion.
Lee M; Ham NY; Hwang CY; Jang J; Lee B; Jeong JW; Kang I; Yeo EJ
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077072
[TBL] [Abstract][Full Text] [Related]
2. Compound C Inhibits B16-F1 Tumor Growth in a Syngeneic Mouse Model Via the Blockage of Cell Cycle Progression and Angiogenesis.
Lee YT; Lim SH; Lee B; Kang I; Yeo EJ
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31200558
[TBL] [Abstract][Full Text] [Related]
3. Relative expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in mouse renal cell carcinoma cells regulates their metastatic potential.
Miyake H; Hara I; Gohji K; Yamanaka K; Hara S; Arakawa S; Nakajima M; Kamidono S
Clin Cancer Res; 1999 Oct; 5(10):2824-9. PubMed ID: 10537348
[TBL] [Abstract][Full Text] [Related]
4. Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential.
Miyake H; Hara I; Yoshimura K; Eto H; Arakawa S; Wada S; Chihara K; Kamidono S
Cancer Res; 1996 May; 56(10):2440-5. PubMed ID: 8625325
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic effect of ZD1839 against murine renal cell carcinoma (RENCA) in an orthotopic mouse model.
Oh HY; Kwon SM; Kim SI; Jae YW; Hong SJ
Urol Int; 2005; 75(2):159-66. PubMed ID: 16123571
[TBL] [Abstract][Full Text] [Related]
6. Neutralization of interleukin-2 retards the growth of mouse renal cancer.
Fukuhara H; Matsumoto A; Kitamura T; Takeuchi T
BJU Int; 2006 Jun; 97(6):1314-21. PubMed ID: 16686731
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of anti-cancer potency of silibinin on murine renal carcinoma RenCa cells in an animal model with an intact immune system.
Yang C; Li F; Ma J; Zhang HB; Jia J; Zeng J; Wang X; He D; Guo P
Anticancer Drugs; 2020 Sep; 31(8):785-791. PubMed ID: 32209841
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a bioluminescent Renca cell line for renal carcinoma research.
Ding J; Wang C; Chang X
Int Urol Nephrol; 2018 Jan; 50(1):55-61. PubMed ID: 28975469
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumor growth through suppression of angiogenesis by brain-specific angiogenesis inhibitor 1 gene transfer in murine renal cell carcinoma.
Kudo S; Konda R; Obara W; Kudo D; Tani K; Nakamura Y; Fujioka T
Oncol Rep; 2007 Oct; 18(4):785-91. PubMed ID: 17786337
[TBL] [Abstract][Full Text] [Related]
10. Sodium stibogluconate interacts with IL-2 in anti-Renca tumor action via a T cell-dependent mechanism in connection with induction of tumor-infiltrating macrophages.
Fan K; Zhou M; Pathak MK; Lindner DJ; Altuntas CZ; Tuohy VK; Borden EC; Yi T
J Immunol; 2005 Nov; 175(10):7003-8. PubMed ID: 16272361
[TBL] [Abstract][Full Text] [Related]
11. MEF2 plays a significant role in the tumor inhibitory mechanism of encapsulated RENCA cells via EGF receptor signaling in target tumor cells.
Martis PC; Dudley AT; Bemrose MA; Gazda HL; Smith BH; Gazda LS
BMC Cancer; 2018 Dec; 18(1):1217. PubMed ID: 30514247
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
[TBL] [Abstract][Full Text] [Related]
13. Trafficking of 'immune' CD4(+)/CD8(+)T-lymphocytes into the RENCA tumour microcirculation in vivo in mice.
Ali SA; Rees RC; Anderson DQ; Reed MW; Goepel JR; Brown NJ
Br J Cancer; 2000 Oct; 83(8):1061-8. PubMed ID: 10993655
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and xenografts via blockade of the cell cycle at G2/M.
Li QQ; Hsu I; Sanford T; Railkar R; Balaji N; Sourbier C; Vocke C; Balaji KC; Agarwal PK
Cell Mol Life Sci; 2018 Mar; 75(5):939-963. PubMed ID: 29071385
[TBL] [Abstract][Full Text] [Related]
15. [Effect of biological response modifiers on a spontaneous murine renal cell carcinoma regression of metastases caused by the streptococcal preparation OK-432].
Tanji S
Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):716-25. PubMed ID: 1875566
[TBL] [Abstract][Full Text] [Related]
16. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis.
Horiguchi A; Sumitomo M; Asakuma J; Asano T; Asano T; Hayakawa M
Clin Cancer Res; 2004 Dec; 10(24):8648-55. PubMed ID: 15623649
[TBL] [Abstract][Full Text] [Related]
17. Expression of angiostatin cDNA in a murine renal cell carcinoma suppresses tumor growth in vivo.
Fukumori T; Nishitani Ma; Naroda T; Onishi T; Oka N; Kanayama Ho; Kagawa S
Urology; 2002 Jun; 59(6):973-7. PubMed ID: 12031397
[TBL] [Abstract][Full Text] [Related]
18. In vivo growth of transitional and renal cell carcinoma cell lines can be suppressed by the adenovirus-mediated expression of a soluble form of vascular endothelial growth factor receptor.
Ichikura H; Eto M; Ueno H; Harada M; Takayama K; Tokuda N; Tatsugami K; Naito S
Oncol Rep; 2006 May; 15(5):1333-7. PubMed ID: 16596207
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M
J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial ASncmtRNA-1 and ASncmtRNA-2 as potent targets to inhibit tumor growth and metastasis in the RenCa murine renal adenocarcinoma model.
Borgna V; Villegas J; Burzio VA; Belmar S; Araya M; Jeldes E; Lobos-González L; Silva V; Villota C; Oliveira-Cruz L; Lopez C; Socias T; Castillo O; Burzio LO
Oncotarget; 2017 Jul; 8(27):43692-43708. PubMed ID: 28620146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
